Recent News

• 09.04.2025 - Aethlon Medical Announces Pricing of $4.5 Million Public Offering
• 09.04.2025 - Aethlon Medical Announces Pricing of $4.5 Million Public Offering
• 09.03.2025 - Aethlon Medical Announces Issuance of Hemopurifier® Patents for the Treatment of Long COVID and COVID-19-associated Coagulopathy (CAC)
• 09.03.2025 - Aethlon Medical Announces Issuance of Hemopurifier® Patents for the Treatment of Long COVID and COVID-19-associated Coagulopathy (CAC)
• 08.13.2025 - Aethlon Medical Announces Financial Results for the Fiscal First Quarter Ended June 30, 2025, and Provides Corporate Update
• 08.13.2025 - Aethlon Medical Announces Financial Results for the Fiscal First Quarter Ended June 30, 2025, and Provides Corporate Update
• 08.05.2025 - Aethlon Medical to Release Fiscal First Quarter Financial Results and Host Conference Call on August 13, 2025
• 08.05.2025 - Aethlon Medical to Release Fiscal First Quarter Financial Results and Host Conference Call on August 13, 2025
• 07.15.2025 - Aethlon Medical, Inc. Announces Positive Data Safety Monitoring Board Review and Recommendation to Advance to Next Clinical Trial Cohort
• 07.15.2025 - Aethlon Medical, Inc. Announces Positive Data Safety Monitoring Board Review and Recommendation to Advance to Next Clinical Trial Cohort

Recent Filings

• 08.29.2025 - S-1/A General form for registration of securities under the Securities Act of 1933
• 08.21.2025 - EX-99.1 EX-99.1
• 08.21.2025 - 8-K Current report
• 08.20.2025 - S-1 General form for registration of securities under the Securities Act of 1933
• 08.20.2025 - 1-A-W Withdrawal of offering statement [Regulation A]
• 08.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 08.13.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 08.13.2025 - EX-99.1 EX-99.1
• 08.13.2025 - 8-K Current report
• 07.25.2025 - DRS Draft Registration Statement